» Articles » PMID: 17138644

The Role of Extranuclear Signaling Actions of Progesterone Receptor in Mediating Progesterone Regulation of Gene Expression and the Cell Cycle

Overview
Journal Mol Endocrinol
Date 2006 Dec 2
PMID 17138644
Citations 100
Authors
Affiliations
Soon will be listed here.
Abstract

Human progesterone receptor (PR) contains a motif that interacts with the SH3 domain of Src and mediates rapid activation of Src and downstream MAPK (Erk-1/-2) without relying on the transcriptional activity of the receptor. Here we investigated the role and intracellular location of this nontranscriptional activity of PR. Progestin activation of Src/MAPK occurred outside the nucleus with the B isoform of PR that was distributed between the cytoplasm and nucleus, but not with PR-A that was predominantly nuclear. Breast cancer cells stably expressing wild-type PR-B or PR-B with disrupting point mutations in the SH3 domain binding motif (PR-BDeltaSH3) that do not affect the transcriptional activity of PR, were compared for effects of progestin on endogenous target gene expression and cell proliferation. Progestin induction of the cyclin D1 gene, which lacks a progesterone response element, was dependent on PR activation of the Src/MAPK pathway, whereas induction of the Sgk (serum and glucocorticoid regulated kinase) gene that contains a functional progesterone response element was unaffected by mutations that interfere with PR activation of Src. Progestin induction of cell cycle progression was also abrogated in cells expressing PR-BDeltaSH3, and no effect of progestin on cyclin D1 expression and cell cycle was observed in the presence of PR-A. These results highlight the importance of PR activation of the Src/MAPK signaling pathway for progesterone-induced transcription of select target genes and cell cycle progression.

Citing Articles

SHP2 is essential for the progesterone-promoted proliferation and migration in breast cancer cell lines.

Wang H, Lee W Front Endocrinol (Lausanne). 2025; 16:1523589.

PMID: 39996064 PMC: 11847685. DOI: 10.3389/fendo.2025.1523589.


Transcriptomic Response of the Ovarian Follicle Complex in Post-Vitellogenic Rainbow Trout to 17α,20β-Dihdroxy-4-pregnen-3-one In Vitro.

Ma H, Gao G, Palti Y, Tripathi V, Birkett J, Weber G Int J Mol Sci. 2024; 25(23).

PMID: 39684392 PMC: 11640809. DOI: 10.3390/ijms252312683.


Progesterone receptor potentiates macropinocytosis through CDC42 in pancreatic ductal adenocarcinoma.

Liao Y, Gai Y, Qian L, Pan H, Zhang Y, Li P Oncogenesis. 2024; 13(1):10.

PMID: 38424455 PMC: 10904380. DOI: 10.1038/s41389-024-00512-7.


A molecular toolbox to study progesterone receptor signaling.

Aarts M, Wagner M, van der Wal T, van Boxtel A, van Amerongen R J Mammary Gland Biol Neoplasia. 2023; 28(1):24.

PMID: 38019315 PMC: 10687192. DOI: 10.1007/s10911-023-09550-0.


Reevaluating the Role of Progesterone in Ovarian Cancer: Is Progesterone Always Protective?.

Mauro L, Spartz A, Austin J, Lange C Endocr Rev. 2023; 44(6):1029-1046.

PMID: 37261958 PMC: 11048595. DOI: 10.1210/endrev/bnad018.